Centogene Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
493
- Latest Deal Type
-
Debt Refin.
- Financing Rounds
-
7
- Investments
-
3
Centogene General Information
Description
Centogene NV is a United States-based company engaged in data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. The company operates in two segments: pharmaceutical and diagnostics. Its pharmaceutical segment provides a variety of services to its pharmaceutical partners, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring. Its diagnostics segment provides targeted genetic sequencing and diagnostics services to patients. Its geographic regions are Europe, the Middle East, North America, and Latin America.
Contact Information
Website
www.centogene.comCorporate Office
- Am Strande 7
- 18055 Rostock
- Germany
Corporate Office
- Am Strande 7
- 18055 Rostock
- Germany
Centogene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Centogene Comparisons
Industry
Financing
Details
Centogene Competitors (6)
One of Centogene’s 6 competitors is Revvity, a Corporation company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Revvity | Corporation | Waltham, MA | ||||
| Intas Pharmaceuticals | Private Equity-Backed | Ahmedabad, India | ||||
| Personalis | Formerly VC-backed | Fremont, CA | ||||
| CeGaT | Corporate Backed or Acquired | Tubingen, Germany | ||||
| Genentech | Formerly VC-backed | South San Francisco, CA |
Centogene Patents
Centogene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4495250-A1 | Method for preparing an rna preparation and use thereof | Inactive | 18-Jul-2023 | ||
| WO-2024175682-A1 | Method for preparing an rna preparation and use thereof | Inactive | 21-Feb-2023 | ||
| AU-2019214384-A1 | Method for the diagnosis of hereditary angioedema | Inactive | 31-Jan-2018 | ||
| CA-3089802-A1 | Method for the diagnosis of hereditary angioedema | Inactive | 31-Jan-2018 | ||
| EP-3521828-A1 | Method for the diagnosis of hereditary angioedema | Inactive | 31-Jan-2018 | G01N33/6893 |
Centogene Signals
Centogene Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Centogene Investments (3)
Centogene’s most recent deal was a Buyout/LBO with Pearl Medical Analysis Laboratory. The deal was made on 09-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Pearl Medical Analysis Laboratory | 09-Jul-2026 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| Joint venture (Centogene / Lifera) | 26-Jun-2023 | Joint Venture | Other Healthcare Services | ||
| Provecs Medical (Laboratory facilities and equipment) | 15-Apr-2020 | Corporate Asset Purchase | Buildings and Property |
Centogene Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Pearl Medical Analysis Laboratory | Abu Dhabi, United Arab Emirates |
Centogene FAQs
-
When was Centogene founded?
Centogene was founded in 2006.
-
Where is Centogene headquartered?
Centogene is headquartered in Rostock, Germany.
-
What is the size of Centogene?
Centogene has 493 total employees.
-
What industry is Centogene in?
Centogene’s primary industry is Drug Discovery.
-
Is Centogene a private or public company?
Centogene is a Private company.
-
What is Centogene’s current revenue?
The current revenue for Centogene is .
-
How much funding has Centogene raised over time?
Centogene has raised $129M.
-
Who are Centogene’s investors?
Charme Capital Partners has invested in Centogene.
-
Who are Centogene’s competitors?
Revvity, Intas Pharmaceuticals, Personalis, CeGaT, and Genentech are some of the 6 competitors of Centogene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process